Foreign Corrupt Practices Act: The Compliance Red Flags for the Healthcare Industry | Descartes

Foreign Corrupt Practices Act: The Compliance Red Flags for the Healthcare Industry

In the early 20th century, bribery of foreign countries was not uncommon for domestic businesses operating internationally. Those with suppliers, distributors, and other partners overseas would often pay bribes and even record them on official invoices as regular business expenses. Doing so would allow them to gain access to new contracts and speed up certain legal processes unethically.

These practices changed with the implementation of the FCPA, which all industries (not just healthcare) must follow to this day. What exactly is the FCPA, what does compliance look like, and what are some red flags to indicate potential non-compliance?

What Is the FCPA?

The FCPA, which stands for Foreign Corrupt Practices Act, is a federal law of the United States instituted in 1977 designed to prevent American individuals and organizations from bribing foreign officials to advance their own business interests.

It does so by requiring domestic companies to implement internal controls and boost recordkeeping procedures to hold everybody accountable.

The FCPA is run jointly by the Securities and Exchange Commission (SEC) and the Department of Justice (DOJ).

Does FCPA Compliance Enforcement Apply to Healthcare?

FCPA compliance is not specific to medical organizations but certainly applies to them. In fact, this industry is primarily susceptible to FCPA compliance violations for a few reasons:

Of course, the Foreign Corrupt Practices Act does apply to all companies in the United States, from publicly traded ones to private ones, whenever they conduct business anywhere in the world.

What Did the FCPA Implement?

Several new responsibilities are now required of American businesses operating internationally. Those include:

It’s worth noting that American businesses largely supported the passing of the FCPA, mainly because it leveled the playing field for domestic organizations abroad. It was difficult to compete in less developed regions where bribery and corruption are more common.

FCPA Compliance Red Flags to Look Out For

Getting caught in violation of the Foreign Corrupt Practices Act can have substantial consequences for the business in question, from costly sanctions and penalties to a loss of trust in the market to even criminal charges. It should be obvious, but the potential losses associated with non-compliance entirely negate the temporary benefit of bribery.

For that reason, it’s important to understand what some red flags look like for a company committing FCPA non-compliance.

The first signs you should look out for include the reputation of the business in the market:

You’ll also need to look at how the company works with the government in its own country:

Strange accounting practices can be another major red flag of FCPA non-compliance:

And don’t forget to check for other miscellaneous circumstances like:

Red flags are merely potential symptoms of FCPA non-compliance and not perfect evidence. However, the next time you work with a foreign party, take note and be cautious should many of these red flags be raised at the same time.

Prevent Breaches of FCPA Compliance with Descartes

The FCPA is only one of many international regulations to keep track of. Preventing the costly sanctions and fines associated with non-compliance is a complicated practice, especially if you’re still using dated manual processes.

If you’re in the market for your industry’s best compliance solutions, you can streamline your approach to regulatory mandates with a partner like Descartes. From denied party screening to global trade intelligence, you’ll find what you need from our automated compliance processes.

Look For Automated Screening Tools From Descartes

FCPA Compliance doesn’t have to be an expensive hassle. Being a data and analytics-heavy process, denied party screening is naturally a field where technology can be leveraged effectively. Healthcare compliance, with so many best practices and individual agencies involved, is too complicated to entrust to a manual business process.

That’s why Descartes has been working with some of the world’s most prominent hospitals to support their work on customs and regulatory compliance. Contact us to learn more about how our tools help boost global trade intelligence and empower denied party screening departments across the country.

For more comprehensive information about effective compliance in the healthcare industry, download our white paper or visit our Resource Center.

Looking to talk to an expert?

Written by Jackson Wood
Director, Industry Strategy, Global Trade Intelligence, Descartes